NHS Lothian

Running trials

• Not yet recruiting

  Protocol for Non-invasive Gynaecological Surveillance in Lynch Syndrome

  NCT07877779· Source

• Recruiting

  Optimising Colorectal Cancer Patient Pathways

  NCT07430540· Source

• Recruiting

  Secondary Care Colorectal Cancer Pathway Review

  NCT07430527· Source

• Active, not recruiting

  Troponin in Acute Chest Pain to Risk Stratify and Guide EffecTive Use of Computed Tomography Coronary Angiography

  NCT03952351· Source

• Recruiting

  Remote Monitoring of Asthma in Children and Young People

  NCT07129616· Source

• Recruiting

  HPV Equity Study: Exploring Cervical Cancer Control in Scotland for Women With Experience of Priority Risks

  NCT06414057· Source

• Recruiting

  Bladder EpiCheck European Haematuria Study

  NCT06818136· Source

• Recruiting

  Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis

  NCT06487273· Source

• Recruiting

  Retinal Vessel Leakage in Cerebral Small Vessel Disease

  NCT06416371· Source

• Recruiting

  MEMRI and Kidney Disease

  NCT06698614· Source

• Recruiting

  The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance

  NCT06117059· Source

• Recruiting

  Fibrosis Associated Protein Inhibitor (FAPI) Radiotracer-based Imaging to Identify Fibrotic Intestinal Crohn's Disease

  NCT07152431· Source

• Recruiting

  Digital App for Speech & Health Monitoring

  NCT06450418· Source

• Active, not recruiting

  Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

  NCT06325020· Source

• Active, not recruiting

  Fatigue in Lupus Intervention Programmes (FLIP)

  NCT06308770· Source

• Recruiting

  The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck

  NCT05808920· Source

• Active, not recruiting

  Point of Care Evaluation of High-sensitivity Cardiac Troponin

  NCT05665127· Source

• Active, not recruiting

  Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer

  NCT05382286· Phase 3· Source

• Recruiting

  A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

  NCT05085028· Phase 3· Source

• Active, not recruiting

  MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis

  NCT04276740· Phase 2· Source

• Recruiting

  Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers

  NCT05604963· Source

• Recruiting

  Awareness Detection and Communication in Disorders of Consciousness

  NCT03827187· Source

• Active, not recruiting

  Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

  NCT04821622· Phase 3· Source

• Active, not recruiting

  Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

  NCT04794101· Phase 3· Source

• Recruiting

  Tessa Jowell BRAIN MATRIX - Platform Study

  NCT04274283· Source

• Active, not recruiting

  IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

  NCT01398085· Phase 2/3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers2 recruiting
• Colorectal cancer2 recruiting
• Stroke2 recruiting
• Asthma1 recruiting
• Bladder cancer1 recruiting
• Cervical cancer1 recruiting
• Chronic kidney disease1 recruiting
• Crohn's disease1 recruiting
• Cystic fibrosis1 recruiting
• Endometrial cancer1 recruiting
• Head and neck cancer1 recruiting
• Lung cancer1 recruiting
• Multiple sclerosis1 recruiting
• Parkinson disease1 recruiting
• Prostate cancer1 recruiting
• Thyroid cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis

  NCT05539625· Phase 2· Source

• Completed

  Bacillus Subtilis in Parkinson's Disease

  NCT06487975· Source

• Completed

  Targeting Investigation and Treatment in Patients With Type 2 Myocardial Infarction

  NCT05419583· Source

• Completed

  Realistic Computational Electrophysiology Simulations for the Targetted Treatment of Atrial Fibrillation

  NCT05057507· Source

• Completed

  A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome

  NCT06734117· Source

• Completed

  Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

  NCT04671433· Phase 3· Source

• Completed

  Lowering Events in Non-proliferative Retinopathy in Scotland

  NCT03439345· Phase 4· Source

• Completed

  Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

  NCT02914535· Phase 3· Source

• Completed

  PAKT: AZD5363 in Combination With Paclitaxel in Triple-Negative Advanced or Metastatic Breast Cancer

  NCT02423603· Phase 2· Source